Target intelligence / Profile preview

V-type proton ATPase 116 kDa subunit a isoform 4 (ATP6V0A4)

Target
ATP6V0A4
Molecular classification
Enzyme (specifically, ATPase), Transporter (proton transporter), Ion channel family (vacuolar-type H+-ATPase)
01

Overview

V-type proton ATPase 116 kDa subunit a isoform 4 (ATP6V0A4) is a membrane-bound component of the multisubunit V-ATPase enzyme complex, responsible for transporting protons across intracellular and plasma membranes through ATP hydrolysis. The a4 isoform is especially critical in the kidney and the inner ear, where it acidifies urine and helps maintain the inner ear’s pH. Mutations in ATP6V0A4 lead to distal renal tubular acidosis, metabolic bone disease, and sensorineural hearing loss. The V-ATPase consists of a cytosolic V1 domain (ATP hydrolysis) and a membrane-embedded V0 domain (proton translocation), with the a4 subunit forming part of the transmembrane channel. While the enzyme complex is a validated physiological target, direct therapeutic modulation is limited because of fundamental cellular roles throughout the body[1][2][3][4][5].

Other names
V-type proton ATPase 116 kDa subunit a 4ATPase H+ transporting V0 subunit a4Vacuolar proton translocating ATPase 116 kDa subunit a isoform 4Vacuolar proton translocating ATPase 116 kDa subunit a kidney isoformV-ATPase subunit a4VPP2RDRTA2RTADRA4ATP6N1BATP6N2DRTA3RTA1CSTV1VPH1
02

Mechanism of action

Inhibition of proton transport (blocks acidification of intracellular/extracellular compartments by inhibiting V-ATPase activity overall; this is the mechanism of generic V-ATPase inhibitors, experimentally used)

03

Biological functions

Intracellular compartment acidificationProton transport across membranesProtein sortingZymogen activationReceptor-mediated endocytosisSynaptic vesicle proton gradient generationUrinary acid secretionSystemic acid–base homeostasis
04

Disease associations

Renal tubular acidosis (distal)Sensorineural hearing lossBone demineralizationElectrolyte disordersOther kidney-related acid–base disorders
05

Safety considerations

Systemic V-ATPase inhibition causes off-target toxicity, due to the enzyme’s ubiquitous role in cellular acid–base homeostasis, endocytosis, and vesicle functionMutations may lead to metabolic acidosis, bone loss, and hearing loss
06

Biomarkers

ATP6V0A4 expression or mutation analysis (for diagnosis of distal renal tubular acidosis with sensorineural hearing loss)

Beyond the preview

Go deeper on V-type proton ATPase 116 kDa subunit a isoform 4 (ATP6V0A4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on V-type proton ATPase 116 kDa subunit a isoform 4 (ATP6V0A4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call